APREA THERAPEUTICS INC APRE

Bearish

ASignal's systematic analysis rates APRE as Bearish.

Reflects the latest available analysis · analyzed Nov 19, 2026

The case on APRE

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Positive RSI indicating neutral-to-bullish momentum
  • Price near upper end of Bollinger Bands suggesting potential breakout
  • Strong liquidity position with current ratio of 9.67x and quick ratio of 9.52x
  • Zero debt and $37.85M in cash providing runway for development
VS
Bear case
  • Negative MACD and price momentum indicating downtrend
  • Massive negative operating margin (-457,872.75%) and unprofitable operations
  • Extremely high price-to-sales (2096.99x) and negative enterprise value
  • No news coverage or Reddit mentions indicating low market interest
  • Negative return on equity (-60.87%) and return on assets (-35.95%)
Subscriber-only

See the full verdict on APRE

ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.

How ASignal analyzes APRE

Most investors never get a second opinion, let alone several. ASignal runs APRE past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

APRE Stock: Bull vs Bear Case, Bearish Read (Nov 2026)